Our research projects
Since 1987 the Macular Society has invested around £10 million in over 100 research projects. Each year we invite applications for research grants, PhD studentships and seedcorn grants which are assessed by our Research Committee.
Research grants
Research grants are for projects of up to three years duration and up to £250,000, which covers everything from laboratory chemicals to salaries.
PhD studentships
A PhD studentship funds a student to undertake a three year research project. The student submits a thesis for qualification of the degree, which is the highest level of academic degree attainable.
Seedcorn projects
A seedcorn grant is funding of up to £25,000 to generate preliminary data to advance innovative and novel ideas.
Using gene editing to stop progression of Stargardt disease
In Stargardt disease, mutations in the ABCA4 gene lead to damage to the macula. This work aims to create healthy ABCA4 protein using gene editing.
Find out more
Real-life costs and benefits of wearable low vision aids
A trial comparing different low vision aids such as magnifiers, smart devices and wearable technology to compare their cost and impact on quality of life
Find out more
Wrong place, wrong time: protein delivery and macular disease
Investigating the movement of a protein called TIMP-3, which may be involved in AMD and Sorsby Fundus Dystrophy. To understand how the mutation leads to dysfunction and disease.
Find out more
New form of gene editing for macular dystrophies
Study testing a new form of CRISPR gene editing to increase expression of a gene. This research could help treat more patients with macular dystrophy.
Find out more
Mutations in CFI gene: which are harmless or harmful?
Analysing mutations in the gene CFI which has been associated with AMD. This research aims to determine which may lead to AMD and which may not.
Find out more
The impact of misaligned daily light cycles on the development of diabetic retinopathy
This research looks into the impact of circadian rhythms on the development of diabetic retinopathy (DR).
Find out more